Doseloop Beta

Insulin Aspart

medication Under review

A rapid-acting insulin analog used to improve glycemic control in patients with diabetes mellitus.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

In healthy human subjects, there are no meaningful supplementation studies for Insulin Aspart because it is a prescription drug used in people with diabetes rather than a wellness supplement. The available human evidence focuses on diabetic populations, where insulin aspart generally produces glycemic control that is at least comparable to regular human insulin and may reduce nocturnal hypoglycemia in some regimens. Because the user requested healthy human subjects only, there are no eligible human studies to include for benefits in healthy people. The main documented risks in human use are insulin-related adverse effects, especially hypoglycemia, which are dose-dependent and clinically important.

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (1 study)

RCT

Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus.

Clinical Therapeutics • 2007 • n=1

Vaag A, Brange J, Lund SS

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 1
Researched benefits 0
Side effects noted 0